Articles Tagged With: acog
-
An Over-the-Counter Birth Control Pill Could Be a Game-Changer
The application for the first OTC birth control pill in the United States marks a new chapter in the ever-changing reproductive healthcare environment of 2022. In June, Perrigo Company announced its HRA Pharma arm submitted an application to the FDA to approve its progestin-only daily birth control pill, Opill, for OTC status.
-
With National Abortion Rights Gone, What Is Next for Providers?
Five Supreme Court justices signaled in the Dobbs v. Jackson Women’s Health Organization oral arguments they were ready to overturn the 1973 Roe v. Wade decision, despite nearly five decades of precedent upholding abortion care as a constitutional right. -
Accessing Hormonal Contraception by Pharmacy Prescriptions
A stopgap step to increasing access to hormonal birth control is to expand prescribing authority to pharmacists. Compared to other clinical settings, pharmacies can be easier for people to access, given their wide distribution across the country and their extended hours of operation. -
FDA Makes Medication Abortion Available Via Telehealth
The FDA enabled reproductive health providers to prescribe mifepristone, the abortion medication, via telemedicine — at least through the duration of the pandemic. The FDA approved lifting the requirement of in-person dispensing of mifepristone, since the COVID-19 pandemic presents additional COVID-related risks to patients and healthcare personnel when patients visit a clinic solely to receive a prescription.
-
FDA Lifts Restriction on Mifepristone Access
Federal rule had required women to pick up the drug in person only, even during the COVID-19 pandemic.
-
For Adolescents, Menstrual Health Is a Vital Sign
From both a global and domestic perspective, reproductive health providers should focus on menstrual health issues with women as part of their overall reproductive wellness and healthcare, according to the authors of a new paper on sexual and reproductive healthcare and rights. Menstruation should be thought of as a vital sign, particularly for adolescents.
-
Researchers Suggest It Is Time to End the Default Pelvic Exam
Women who seek most forms of contraception do not need a routine pelvic examination before they are prescribed a contraceptive. Still, these exams are routine for many OB/GYN offices and reproductive health clinics, and this creates a barrier for some women — particularly those who have experienced sexual assault and intimate partner violence, according to new research.
-
Data reaffirm the effectiveness of LNG, copper intrauterine devices
Findings from a recent analysis of data from a large, multi-country study of women using levonorgestrel or copper intrauterine devices (IUDs) indicate that while both forms of contraception have high levels of efficacy, the levonorgestrel device daily releasing 20 mcg was associated with a significantly lower risk of pregnancy, including ectopic pregnancy, than copper IUDs.